Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticonvulsant drugs and thyroid hormones in children with epilepsy
IRCT20250622066215N1Phase 4Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clobazam, phenobarbital, carbamazepine and levetiracetam in epilepsy (4 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Change in thyroid stimulating hormone, Change in free thyroxine and 3 more. Started Oct 2025; status: completed.
02
Drugs
clobazamphenobarbitalcarbamazepinelevetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20250622066215N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250622066215N1.